236 related articles for article (PubMed ID: 17545117)
21. Anderson-Fabry disease and the heart.
O'Mahony C; Elliott P
Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.
Dubuc V; Moore DF; Gioia LC; Saposnik G; Selchen D; Lanthier S
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1288-92. PubMed ID: 23168217
[TBL] [Abstract][Full Text] [Related]
23. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.
Shimohata H; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M
CEN Case Rep; 2020 Aug; 9(3):237-242. PubMed ID: 32189245
[TBL] [Abstract][Full Text] [Related]
24. Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications.
Meehan SM; Junsanto T; Rydel JJ; Desnick RJ
Am J Kidney Dis; 2004 Jan; 43(1):164-71. PubMed ID: 14712441
[TBL] [Abstract][Full Text] [Related]
25. Fabry disease.
Germain DP
Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
[TBL] [Abstract][Full Text] [Related]
26. Fabry disease: treatment and diagnosis.
Rozenfeld PA
IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
[TBL] [Abstract][Full Text] [Related]
27. Enzyme replacement therapy for Fabry disease, an inherited nephropathy.
Desnick RJ; Banikazemi M; Wasserstein M
Clin Nephrol; 2002 Jan; 57(1):1-8. PubMed ID: 11837797
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
[TBL] [Abstract][Full Text] [Related]
29. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease.
Kes VB; Cesarik M; Zavoreo I; Soldo-Butković S; Kes P; Basić-Jukić N; Racki S; Jakić M; Delić-Brkljacić D; Jukić Z; Trkanjec Z; Serić V; Solter VV; Bielen I; Basić S; Demarin V; ; ; ;
Acta Clin Croat; 2013 Sep; 52(3):395-405. PubMed ID: 24558776
[TBL] [Abstract][Full Text] [Related]
31. [Neurological complications of Fabry-disease].
Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous complications of Anderson-Fabry disease.
Giuseppe P; Daniele R; Rita BM
Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
[TBL] [Abstract][Full Text] [Related]
33. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.
Whybra C; Kampmann C; Willers I; Davies J; Winchester B; Kriegsmann J; Brühl K; Gal A; Bunge S; Beck M
J Inherit Metab Dis; 2001 Dec; 24(7):715-24. PubMed ID: 11804208
[TBL] [Abstract][Full Text] [Related]
34. Clinical spectrum of Anderson Fabry disease in a Romanian family.
Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
[TBL] [Abstract][Full Text] [Related]
35. [Management of Fabry disease].
Constantin T; Székely A; Ponyi A; Gulácsy V; Ambrus C; Kádár K; Vastagh I; Dajnoki A; Tóth B; Bokrétás G; Müller V; Katona M; Medvecz M; Fiedler O; Széchey R; Varga E; Rudas G; Kertész A; Molnár S; Kárpáti S; Nagy V; Magyar P; Mahdi M; Rákóczi E; Németh K; Bereczki D; Garami M; Erdos M; Maródi L; Fekete G
Orv Hetil; 2010 Aug; 151(31):1243-51. PubMed ID: 20656661
[TBL] [Abstract][Full Text] [Related]
36. [Fabry disease--diagnostic guideline].
Constantin T; Rákóczi E; Ponyi A; Ambrus C; Kádár K; Vastagh I; Dajnoki A; Tóth B; Bokrétás G; Müller V; Katona M; Csikós M; Fiedler O; Széchey R; Varga E; Rudas G; Kertész A; Molnár S; Kárpáti S; Nagy V; Magyar P; Mahdi M; Németh K; Bereczki D; Garami M; Erdos M; Maródi L; Fekete G;
Orv Hetil; 2010 Feb; 151(7):243-9. PubMed ID: 20133243
[TBL] [Abstract][Full Text] [Related]
37. Vasculopathy in patients with Fabry disease: current controversies and research directions.
Rombach SM; Twickler TB; Aerts JM; Linthorst GE; Wijburg FA; Hollak CE
Mol Genet Metab; 2010 Feb; 99(2):99-108. PubMed ID: 19900828
[TBL] [Abstract][Full Text] [Related]
38. Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD).
Lidove O; Kaminsky P; Hachulla E; Leguy-Seguin V; Lavigne C; Marie I; Maillot F; Serratrice C; Masseau A; Chérin P; Cabane J; Noel E;
Clin Genet; 2012 Jun; 81(6):571-7. PubMed ID: 21623772
[TBL] [Abstract][Full Text] [Related]
39. [Fabry's disease in children. Clinical and biological study of one family. Structure and ultrastructure of the kidney in a hemizygote and a heterozygote].
Desbois JC; Mazière JC; Gubler MC; Allaneau C; Verhaeghe MP; Herrault A
Ann Pediatr (Paris); 1977 Sep; 24(8-9):575-86. PubMed ID: 16211911
[No Abstract] [Full Text] [Related]
40. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]